They are a newly organized blank check company incorporated on February 22, 2021 as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which they refer to throughout this prospectus as their initial business combination. They have not selected any specific business combination target and they have not, nor has anyone on their behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. They have generated no operating revenues to date and they do not expect that they will generate operating revenues until they consummate their initial business combination. While they may pursue an acquisition opportunity in any business, industry, sector or geographical location, they intend to focus on industries that complement their management team’s background, and to capitalize on the ability of their management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, they will target North American or European companies in the life sciences and medical technology sectors where their management has extensive investment experience. They may pursue a transaction in which their shareholders immediately prior to the completion of their initial business combination would collectively own a minority interest in the post-business combination company.